clinical trial Archive — Page 2 of 16

Colorized scanning electron micrograph showing numerous rod-shaped Escherichia coli bacteria clustered together against a dark background.
April 18, 2026

Rapid bloodstream infection testing shows high potential for timely, lifesaving treatment: Study

Gram-negative bacteria bloodstream infections are a major cause of illness and death worldwide, especially where antimicrobial resistance is more common.  

pregnant belly
April 10, 2026

Weekly buprenorphine injection proves more effective for pregnant women with opioid use disorder

Vanderbilt Health’s Firefly program continues to lead the way in caring for pregnant women with substance use disorder.

Research-study flyer showing a doctor speaking with a patient. Large text asks, “Have you recently started medication for opioid use disorder (MOUD)?” It states that VUMC seeks volunteers for a study of investigational tirzepatide, marketed as Mounjaro and Zepbound, in new MOUD patients prescribed buprenorphine, and provides phone number 615-587-9669 for confidential information.
March 26, 2026

Those who recently started medication for opioid use disorder needed for study

Smiling man in a blue shirt photographed outdoors at sunset, with water and a railing in the background.
March 18, 2026

Vanderbilt Center for Cognitive Medicine enrolls first Down syndrome participant for Alzheimer’s disease study

Evan Dewey and his family travel from Atlanta to participate in the ABATE study, a clinical trial evaluating a treatment that could reduce the likelihood of Alzheimer’s disease development in individuals with Down syndrome

Seven masked medical team members in surgical attire pose in a procedure room, with medical equipment behind them; one holds a white handheld device.
March 18, 2026

Vanderbilt Health uses novel robotic device to place central lines in FDA trial  

A Chattanooga patient says she’s feeling great after becoming the first to receive the robotic‑assisted central line in Nashville.

(iStock image)
March 11, 2026

Clinical trial to test implant for stress urinary incontinence in men

SUI, or involuntary urinary leakage, affects an estimated 40 million Americans and 90 million Europeans.